103 related articles for article (PubMed ID: 26388461)
1. AAV6-mediated Cardiac-specific Overexpression of Ribonucleotide Reductase Enhances Myocardial Contractility.
Kolwicz SC; Odom GL; Nowakowski SG; Moussavi-Harami F; Chen X; Reinecke H; Hauschka SD; Murry CE; Mahairas GG; Regnier M
Mol Ther; 2016 Feb; 24(2):240-250. PubMed ID: 26388461
[TBL] [Abstract][Full Text] [Related]
2. Cell-based delivery of dATP via gap junctions enhances cardiac contractility.
Lundy SD; Murphy SA; Dupras SK; Dai J; Murry CE; Laflamme MA; Regnier M
J Mol Cell Cardiol; 2014 Jul; 72():350-9. PubMed ID: 24780238
[TBL] [Abstract][Full Text] [Related]
3. A single direct injection into the left ventricular wall of an adeno-associated virus 9 (AAV9) vector expressing extracellular superoxide dismutase from the cardiac troponin-T promoter protects mice against myocardial infarction.
Prasad KM; Smith RS; Xu Y; French BA
J Gene Med; 2011 Jun; 13(6):333-41. PubMed ID: 21674736
[TBL] [Abstract][Full Text] [Related]
4. Gene Therapy Rescues Cardiac Dysfunction in Duchenne Muscular Dystrophy Mice by Elevating Cardiomyocyte Deoxy-Adenosine Triphosphate.
Kolwicz SC; Hall JK; Moussavi-Harami F; Chen X; Hauschka SD; Chamberlain JS; Regnier M; Odom GL
JACC Basic Transl Sci; 2019 Nov; 4(7):778-791. PubMed ID: 31998848
[TBL] [Abstract][Full Text] [Related]
5. Transgenic overexpression of ribonucleotide reductase improves cardiac performance.
Nowakowski SG; Kolwicz SC; Korte FS; Luo Z; Robinson-Hamm JN; Page JL; Brozovich F; Weiss RS; Tian R; Murry CE; Regnier M
Proc Natl Acad Sci U S A; 2013 Apr; 110(15):6187-92. PubMed ID: 23530224
[TBL] [Abstract][Full Text] [Related]
6. A simple adeno-associated virus-based approach for the generation of cardiac genetic models in rats.
Schlesinger-Laufer M; Douvdevany G; Haimovich-Caspi L; Zohar Y; Shofty R; Kehat I
F1000Res; 2020; 9():. PubMed ID: 33604024
[No Abstract] [Full Text] [Related]
7. Cell based dATP delivery as a therapy for chronic heart failure.
Mhatre KN; Mathieu J; Martinson A; Flint G; Blakley LP; Tabesh A; Reinecke H; Yang X; Guan X; Murali E; Klaiman JM; Odom GL; Brown MB; Tian R; Hauschka SD; Raftery D; Moussavi-Harami F; Regnier M; Murry CE
bioRxiv; 2023 Apr; ():. PubMed ID: 37162854
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of Readministration of a Recombinant Adeno-Associated Virus Vector Expressing Acid Alpha-Glucosidase in Pompe Disease: Preclinical to Clinical Planning.
Corti M; Cleaver B; Clément N; Conlon TJ; Faris KJ; Wang G; Benson J; Tarantal AF; Fuller D; Herzog RW; Byrne BJ
Hum Gene Ther Clin Dev; 2015 Sep; 26(3):185-93. PubMed ID: 26390092
[TBL] [Abstract][Full Text] [Related]
9. E Pluribus Unum: 50 Years of Research, Millions of Viruses, and One Goal--Tailored Acceleration of AAV Evolution.
Grimm D; Zolotukhin S
Mol Ther; 2015 Dec; 23(12):1819-31. PubMed ID: 26388463
[TBL] [Abstract][Full Text] [Related]
10. Comparison of Human Embryonic Stem Cell-Derived Cardiomyocytes, Cardiovascular Progenitors, and Bone Marrow Mononuclear Cells for Cardiac Repair.
Fernandes S; Chong JJH; Paige SL; Iwata M; Torok-Storb B; Keller G; Reinecke H; Murry CE
Stem Cell Reports; 2015 Nov; 5(5):753-762. PubMed ID: 26607951
[TBL] [Abstract][Full Text] [Related]
11. Efficient and Targeted Transduction of Nonhuman Primate Liver With Systemically Delivered Optimized AAV3B Vectors.
Li S; Ling C; Zhong L; Li M; Su Q; He R; Tang Q; Greiner DL; Shultz LD; Brehm MA; Flotte TR; Mueller C; Srivastava A; Gao G
Mol Ther; 2015 Dec; 23(12):1867-76. PubMed ID: 26403887
[TBL] [Abstract][Full Text] [Related]
12. The advancement of human pluripotent stem cell-derived therapies into the clinic.
Thies RS; Murry CE
Development; 2015 Sep; 142(18):3077-84. PubMed ID: 26395136
[TBL] [Abstract][Full Text] [Related]
13. Targeted CRISPR activation is functional in engineered human pluripotent stem cells but undergoes silencing after differentiation into cardiomyocytes and endothelium.
Karbassi E; Padgett R; Bertero A; Reinecke H; Klaiman JM; Yang X; Hauschka SD; Murry CE
Cell Mol Life Sci; 2024 Feb; 81(1):95. PubMed ID: 38372898
[TBL] [Abstract][Full Text] [Related]
14. Echocardiography to Assess Cardiac Structure and Function in Genetic Cardiomyopathies.
Flint G; Kooiker K; Moussavi-Harami F
Methods Mol Biol; 2024; 2735():1-15. PubMed ID: 38038840
[TBL] [Abstract][Full Text] [Related]
15. Bioengineered Hybrid Rep 2/6 Gene Improves Encapsulation of a Single-Stranded Expression Cassette into AAV6 Vectors.
Tejero M; Duzenli OF; Caine C; Kuoch H; Aslanidi G
Genes (Basel); 2023 Sep; 14(10):. PubMed ID: 37895215
[TBL] [Abstract][Full Text] [Related]
16. Multiscale computational modeling of the effects of 2'-deoxy-ATP on cardiac muscle calcium handling.
Hock MT; Teitgen AE; McCabe KJ; Hirakis SP; Huber GA; Regnier M; Amaro RE; McCammon JA; McCulloch AD
J Appl Phys; 2023 Aug; 134(7):074905. PubMed ID: 37601331
[TBL] [Abstract][Full Text] [Related]
17. Identification of Hub Genes in the Remodeling of Non-Infarcted Myocardium Following Acute Myocardial Infarction.
Wang L; Zhang Y; Yu M; Yuan W
J Cardiovasc Dev Dis; 2022 Nov; 9(12):. PubMed ID: 36547406
[TBL] [Abstract][Full Text] [Related]
18. dATP elevation induces myocardial metabolic remodeling to support improved cardiac function.
Mhatre KN; Murray JD; Flint G; McMillen TS; Weber G; Shakeri M; Tu AY; Steczina S; Weiss R; Marcinek DJ; Murry CE; Raftery D; Tian R; Moussavi-Harami F; Regnier M
J Mol Cell Cardiol; 2023 Feb; 175():1-12. PubMed ID: 36470336
[TBL] [Abstract][Full Text] [Related]
19. RRM2 Alleviates Doxorubicin-Induced Cardiotoxicity through the AKT/mTOR Signaling Pathway.
Jiao Y; Li Y; Zhang J; Zhang S; Zha Y; Wang J
Biomolecules; 2022 Feb; 12(2):. PubMed ID: 35204799
[TBL] [Abstract][Full Text] [Related]
20. Human iPSC model reveals a central role for NOX4 and oxidative stress in Duchenne cardiomyopathy.
Duelen R; Costamagna D; Gilbert G; De Waele L; Goemans N; Desloovere K; Verfaillie CM; Sipido KR; Buyse GM; Sampaolesi M
Stem Cell Reports; 2022 Feb; 17(2):352-368. PubMed ID: 35090586
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
